Program details
-
Diabetes across the life course (K)
Diabetes across the life course: national cohort and registry initiatives from the Korea National Institute of Health
Chair(s): Jae-Hwan Nam, Dae Jung Kim
Friday 16 October, 09:00~10:20
Room 6
-
The risk of diabetes is not confined to a single stage of life—it begins in pregnancy, extends across generations, and evolves from childhood into older age. This special session brings together three ongoing diabetes research programs conducted with the Korea National Institute of Health, KDCA, with future directions discussed alongside the Korean Diabetes Association. The first presentation examines how gestational diabetes shapes both maternal progression to type 2 diabetes and intergenerational risk, drawing on a prospective family cohort. The second presents the epidemiology of diabetes in Korean children and adolescents and a national registry supporting prevention and care research. The third addresses evidence-based strategies for optimal diabetes management in Korean older adults. Together, these initiatives show how connected national cohorts and registries can translate life-course evidence into prevention and precision care.
-
-
SIS1-L1
Soo Heon KwakSeoul National University, Korea
-
Gestational diabetes as a window into life-course diabetes risk
-
SIS1-L2
Jaehyun KimSeoul National University, Korea
-
Youth-onset diabetes in Korea: epidemiology and a national registry for prevention and care
-
SIS1-L3
Jae-Seung YunThe Catholic University of Korea, Korea
-
Toward optimal diabetes care in Korean older adults through evidence-based management strategies
- Panel discussion
-
-
SIS1-P1
Joo Hyun LimNational Institute of Health, Korea
-
SIS1-P2
Joon Ho MoonSeoul National University, Korea
-
SIS1-P3
Ji Yoon KimSungkyunkwan University, Korea
-
SIS1-P4
Hanna JungHallym University, Korea
-
Year in review and perspective
Year in review and perspective
Chair(s): Seungjoon Oh, Dong Jun Kim
Friday 16 October, 16:00~17:20
Room 2
-
The Year in Review and Perspective session highlights the most influential advances and landmark studies in the field of diabetes and metabolic diseases over the past year. By integrating perspectives from both clinical and basic research, this session provides a comprehensive overview of emerging trends, transformative discoveries, and their implications for future research and clinical practice. It offers attendees valuable insights into the current landscape of the field while identifying key challenges and opportunities that will shape the next generation of diabetes and metabolic medicine.
-
-
SIS2-L1
Eun-Jung RheeSungkyunkwan University, Korea
-
Year in review and perspectives in the field of diabetes: clinical
-
SIS2-L2
Eun Hee KohUniversity of Ulsan, Korea
-
From mechanisms to medicines: key discoveries in diabetes research 2026
-
Asian expert consensus on diabetic neuropathy
Harmonizing clinical practice: bridging regional disparities and establishing an Asian consensus on diabetic neuropathy (DPN) management
Chair(s): Tae Sun Park, Bin Lu
Friday 16 October, 16:00~17:20
Room 4
-
This Asian expert consensus session addresses regional differences in diabetic neuropathy screening, diagnosis, and management, with emphasis on guideline harmonization and real-world feasibility. By comparing clinical phenotypes and treatment approaches across Asia, the session aims to strengthen practical, culturally adaptable recommendations for painful diabetic neuropathy. Its significance lies in advancing a shared Asian framework for more equitable and effective care.
-
-
SIS3-L1
Bin LuFudan University, China
-
Comparative analysis of DPN screening and diagnostic protocols across Asian guidelines: addressing resource-limited settings
-
SIS3-L2
Heung Yong JinJeonbuk National University, Korea
-
Defining the Asian phenotype: distinct clinical and pathogenetic characteristics of DPN in diverse Asian populations
-
SIS3-L3
Rayaz A MalikHamad Medical Center, Qatar
-
Regional variations in pharmacological management of painful DPN: a review of first-line agents and access to novel therapies
- Panel discussion
-
-
SIS3-P1
Tae Jung OhSeoul National University, Korea
-
SIS3-P2
Jeehee YoonChonnam National University, Korea
-
SIS3-P3
Seon Mee KangSoonchunhyang University, Korea
-
Rising star symposium
Rising star symposium
Chair(s): Min Kyong Moon, Woo Je Lee
Saturday 17 October, 13:30~14:50
Room 1
-
The Rising Star Symposium highlights outstanding early-career investigators whose innovative research is shaping the future of diabetes and metabolic medicine. Covering cutting-edge discoveries from both basic and clinical science, the session provides a platform for emerging scientific leaders to present their latest work, exchange ideas, and foster future collaborations. By showcasing the next generation of researchers, the symposium offers attendees a unique opportunity to gain insights into the evolving landscape of diabetes and metabolism research.
-
-
SIS4-L1
Joon Ho MoonSeoul National University, Korea
-
Lactation-driven metabolic reprogramming of adipose tissue
-
SIS4-L2
Joonyub LeeThe Catholic University of Korea, Korea
-
CGM-derived glycemic trajectories reflect β-cell decline across dysglycemia
-
SIS4-L3
Hanna JungHallym University, Korea
-
Hidden in plain sight: redefining risk through lipids, adiposity, and pregnancy in metabolic disease
-
SIS4-L4
Sang-Hyeon JuKAIST, Korea
-
Sympathetic circuit heterogeneity in multi-organ metabolic regulation
